FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

34793711000001101: Ponatinib 15mg tablets 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105524401000001117 Ponatinib 15mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105524501000001118 Ponatinib 15mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ponatinib 15mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ponatinib true Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has VMP Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has basis of strength substance Ponatinib true Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has presentation strength numerator value 15 false Inferred relationship Existential restriction modifier 1
Ponatinib 15mg tablets 30 tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Ponatinib 15mg tablets 30 tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Ponatinib 15mg tablets 30 tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Ponatinib 15mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has specific active ingredient Ponatinib hydrochloride true Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Iclusig 15mg tablets (Incyte Biosciences UK Ltd) 30 tablet Is a True Ponatinib 15mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start